glutathion et cancer du poumon Les antioxydants doperaient le risque de Utilizing glutathione-triggered nanoparticles to enhance
Description
Important upfront: in the Western pharmaceutical world BPC-157 never passed Phase 3 trials (= the large clinical trials required before drug approval)
Antioxidant : (Antioxidant) 3
Nevertheless, the level of glutathione in the body tends to decrease with age, consequently making the cells more prone to oxidative damage and contributing to cellular ageing
doi: 10.1093/aje/kww212 12
